APO Research
Talk to an analyst

APO RESEARCH · REPORT

Spatial Omics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Spatial Omics Market Outlook and Growth Opportunities 2026

31 December 2025201 pages

Choose your research edition.

Industry ResearchSpatial Omics Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Spatial Omics Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Spatial Omics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Spatial Omics Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Spatial Omics Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Spatial Omics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Spatial Omics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Spatial Omics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Spatial Omics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Spatial Omics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Spatial Omics market include Akoya Biosciences, Biognosys AG, BioSpyder Technologies, Bio-Techne, Brooks Automation, Bruker Corporation, Danaher Corporation, Diagenode Diagnostics and Dovetail Genomics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Spatial Omics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Spatial Omics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Spatial Omics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Spatial Omics market.

Spatial Omics Segment by Company

Akoya Biosciences

Biognosys AG

BioSpyder Technologies

Bio-Techne

Brooks Automation

Bruker Corporation

Danaher Corporation

Diagenode Diagnostics

Dovetail Genomics

IonPath

Nanostring Technologies

PerkinElmer

Rebus Biosystems

S2 Genomics

Seven Bridges Genomics

Vizgen Corporation

Spatial Omics Segment by Type

Spatial Transcriptomic

Spatial Genomics

Spatial Proteomics

Spatial Omics Segment by Application

Laboratory

Research Institutions

Other

Spatial Omics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Spatial Omics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Spatial Omics key companies, revenue, market share, and recent developments.

3. To split the Spatial Omics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Spatial Omics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Spatial Omics significant trends, drivers, influence factors in global and regions.

6. To analyze Spatial Omics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spatial Omics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Spatial Omics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spatial Omics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Spatial Omics industry.

Chapter 3: Detailed analysis of Spatial Omics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Spatial Omics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Spatial Omics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Spatial Omics Industry Trends Table 2. Spatial Omics Industry Drivers Table 3. Spatial Omics Industry Opportunities and Challenges Table 4. Spatial Omics Industry Restraints Table 5. Global Spatial Omics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Spatial Omics Revenue Share by Company (2021-2026) Table 7. Global Spatial Omics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Spatial Omics Key Company Manufacturing Base & Headquarters Table 9. Global Spatial Omics Company, Product Type & Application Table 10. Global Spatial Omics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Spatial Omics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Spatial Transcriptomic Table 15. Significant Companies of Spatial Genomics Table 16. Significant Companies of Spatial Proteomics Table 17. Global Spatial Omics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Spatial Omics Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Spatial Omics Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Spatial Omics Sales Value Share by Type (2021-2026) Table 21. Global Spatial Omics Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Laboratory Table 23. Significant Companies of Research Institutions Table 24. Significant Companies of Other Table 25. Global Spatial Omics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Spatial Omics Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Spatial Omics Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Spatial Omics Sales Value Share by Application (2021-2026) Table 29. Global Spatial Omics Sales Value Share by Application (2027-2032) Table 30. Global Spatial Omics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Spatial Omics Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Spatial Omics Sales Value Share by Region (2021-2026) Table 33. Global Spatial Omics Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Spatial Omics Sales Value Share by Region (2027-2032) Table 35. Global Spatial Omics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Spatial Omics Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Spatial Omics Sales Value Market Share by Country (2021-2026) Table 38. Global Spatial Omics Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Spatial Omics Sales Value Market Share by Country (2027-2032) Table 40. Akoya Biosciences Company Information Table 41. Akoya Biosciences Business Overview Table 42. Akoya Biosciences Spatial Omics Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Akoya Biosciences Spatial Omics Product Portfolio Table 44. Akoya Biosciences Recent Development Table 45. Biognosys AG Company Information Table 46. Biognosys AG Business Overview Table 47. Biognosys AG Spatial Omics Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Biognosys AG Spatial Omics Product Portfolio Table 49. Biognosys AG Recent Development Table 50. BioSpyder Technologies Company Information Table 51. BioSpyder Technologies Business Overview Table 52. BioSpyder Technologies Spatial Omics Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. BioSpyder Technologies Spatial Omics Product Portfolio Table 54. BioSpyder Technologies Recent Development Table 55. Bio-Techne Company Information Table 56. Bio-Techne Business Overview Table 57. Bio-Techne Spatial Omics Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Bio-Techne Spatial Omics Product Portfolio Table 59. Bio-Techne Recent Development Table 60. Brooks Automation Company Information Table 61. Brooks Automation Business Overview Table 62. Brooks Automation Spatial Omics Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Brooks Automation Spatial Omics Product Portfolio Table 64. Brooks Automation Recent Development Table 65. Bruker Corporation Company Information Table 66. Bruker Corporation Business Overview Table 67. Bruker Corporation Spatial Omics Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Bruker Corporation Spatial Omics Product Portfolio Table 69. Bruker Corporation Recent Development Table 70. Danaher Corporation Company Information Table 71. Danaher Corporation Business Overview Table 72. Danaher Corporation Spatial Omics Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Danaher Corporation Spatial Omics Product Portfolio Table 74. Danaher Corporation Recent Development Table 75. Diagenode Diagnostics Company Information Table 76. Diagenode Diagnostics Business Overview Table 77. Diagenode Diagnostics Spatial Omics Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Diagenode Diagnostics Spatial Omics Product Portfolio Table 79. Diagenode Diagnostics Recent Development Table 80. Dovetail Genomics Company Information Table 81. Dovetail Genomics Business Overview Table 82. Dovetail Genomics Spatial Omics Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Dovetail Genomics Spatial Omics Product Portfolio Table 84. Dovetail Genomics Recent Development Table 85. IonPath Company Information Table 86. IonPath Business Overview Table 87. IonPath Spatial Omics Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. IonPath Spatial Omics Product Portfolio Table 89. IonPath Recent Development Table 90. Nanostring Technologies Company Information Table 91. Nanostring Technologies Business Overview Table 92. Nanostring Technologies Spatial Omics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Nanostring Technologies Spatial Omics Product Portfolio Table 94. Nanostring Technologies Recent Development Table 95. PerkinElmer Company Information Table 96. PerkinElmer Business Overview Table 97. PerkinElmer Spatial Omics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. PerkinElmer Spatial Omics Product Portfolio Table 99. PerkinElmer Recent Development Table 100. Rebus Biosystems Company Information Table 101. Rebus Biosystems Business Overview Table 102. Rebus Biosystems Spatial Omics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Rebus Biosystems Spatial Omics Product Portfolio Table 104. Rebus Biosystems Recent Development Table 105. S2 Genomics Company Information Table 106. S2 Genomics Business Overview Table 107. S2 Genomics Spatial Omics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. S2 Genomics Spatial Omics Product Portfolio Table 109. S2 Genomics Recent Development Table 110. Seven Bridges Genomics Company Information Table 111. Seven Bridges Genomics Business Overview Table 112. Seven Bridges Genomics Spatial Omics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Seven Bridges Genomics Spatial Omics Product Portfolio Table 114. Seven Bridges Genomics Recent Development Table 115. Vizgen Corporation Company Information Table 116. Vizgen Corporation Business Overview Table 117. Vizgen Corporation Spatial Omics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Vizgen Corporation Spatial Omics Product Portfolio Table 119. Vizgen Corporation Recent Development Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Spatial Omics Product Image Figure 2. Global Spatial Omics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Spatial Omics Market Size (2021-2032) & (US$ Million) Figure 4. Global Spatial Omics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Spatial Transcriptomic Image Figure 8. Spatial Genomics Image Figure 9. Spatial Proteomics Image Figure 10. Global Spatial Omics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Spatial Omics Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Spatial Omics Sales Value Share by Type (2021-2032) Figure 13. Laboratory Image Figure 14. Research Institutions Image Figure 15. Other Image Figure 16. Global Spatial Omics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Spatial Omics Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Spatial Omics Sales Value Share by Application (2021-2032) Figure 19. Global Spatial Omics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Spatial Omics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Spatial Omics Sales Value (2021-2032) & (US$ Million) Figure 22. North America Spatial Omics Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Spatial Omics Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Spatial Omics Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Spatial Omics Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Spatial Omics Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Spatial Omics Sales Value (2021-2032) & (US$ Million) Figure 28. South America Spatial Omics Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Spatial Omics Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Spatial Omics Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Spatial Omics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Spatial Omics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Spatial Omics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Spatial Transcriptomic
  • Spatial Genomics
  • Spatial Proteomics
Applications
  • Laboratory
  • Research Institutions
  • Other
Companies covered
  • Akoya Biosciences
  • Biognosys AG
  • BioSpyder Technologies
  • Bio-Techne
  • Brooks Automation
  • Bruker Corporation
  • Danaher Corporation
  • Diagenode Diagnostics
  • Dovetail Genomics
  • IonPath
  • Nanostring Technologies
  • PerkinElmer
  • Rebus Biosystems
  • S2 Genomics
  • Seven Bridges Genomics
  • Vizgen Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Spatial Omics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Spatial Omics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Spatial Omics Market Dynamics
  1. 2.1 Spatial Omics Industry Trends
  2. 2.2 Spatial Omics Industry Drivers
  3. 2.3 Spatial Omics Industry Opportunities and Challenges
  4. 2.4 Spatial Omics Industry Restraints
3 Spatial Omics Market by Company
  1. 3.1 Global Spatial Omics Company Revenue Ranking in 2025
  2. 3.2 Global Spatial Omics Revenue by Company (2021-2026)
  3. 3.3 Global Spatial Omics Company Ranking (2024-2026)
  4. 3.4 Global Spatial Omics Company Manufacturing Base and Headquarters
  5. 3.5 Global Spatial Omics Company Product Type and Application
  6. 3.6 Global Spatial Omics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Spatial Omics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Spatial Omics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Spatial Omics Market by Type
  1. 4.1 Spatial Omics Type Introduction
  2. 4.1.1 Spatial Transcriptomic
  3. 4.1.2 Spatial Genomics
  4. 4.1.3 Spatial Proteomics
  5. 4.2 Global Spatial Omics Sales Value by Type
  6. 4.2.1 Global Spatial Omics Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Spatial Omics Sales Value by Type (2021-2032)
  8. 4.2.3 Global Spatial Omics Sales Value Share by Type (2021-2032)
5 Spatial Omics Market by Application
  1. 5.1 Spatial Omics Application Introduction
  2. 5.1.1 Laboratory
  3. 5.1.2 Research Institutions
  4. 5.1.3 Other
  5. 5.2 Global Spatial Omics Sales Value by Application
  6. 5.2.1 Global Spatial Omics Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Spatial Omics Sales Value by Application (2021-2032)
  8. 5.2.3 Global Spatial Omics Sales Value Share by Application (2021-2032)
6 Spatial Omics Regional Value Analysis
  1. 6.1 Global Spatial Omics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Spatial Omics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Spatial Omics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Spatial Omics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Spatial Omics Sales Value (2021-2032)
  7. 6.3.2 North America Spatial Omics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Spatial Omics Sales Value (2021-2032)
  10. 6.4.2 Europe Spatial Omics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Spatial Omics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Spatial Omics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Spatial Omics Sales Value (2021-2032)
  16. 6.6.2 South America Spatial Omics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Spatial Omics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Spatial Omics Sales Value Share by Country, 2025 VS 2032
7 Spatial Omics Country-level Value Analysis
  1. 7.1 Global Spatial Omics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Spatial Omics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Spatial Omics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Spatial Omics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Spatial Omics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Spatial Omics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Spatial Omics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Spatial Omics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Spatial Omics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Spatial Omics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Spatial Omics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Spatial Omics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Spatial Omics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Spatial Omics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Spatial Omics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Spatial Omics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Spatial Omics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Spatial Omics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Spatial Omics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Spatial Omics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Spatial Omics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Spatial Omics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Spatial Omics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Spatial Omics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Spatial Omics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Spatial Omics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Spatial Omics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Spatial Omics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Spatial Omics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Spatial Omics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Spatial Omics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Spatial Omics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Spatial Omics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Spatial Omics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Spatial Omics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Spatial Omics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Spatial Omics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Spatial Omics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Spatial Omics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Spatial Omics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Spatial Omics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Spatial Omics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Spatial Omics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Spatial Omics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Spatial Omics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Spatial Omics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Spatial Omics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Spatial Omics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Spatial Omics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Spatial Omics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Spatial Omics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Spatial Omics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Spatial Omics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Spatial Omics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Spatial Omics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Spatial Omics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Spatial Omics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Spatial Omics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Spatial Omics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Spatial Omics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Spatial Omics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Spatial Omics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Spatial Omics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Spatial Omics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Spatial Omics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Spatial Omics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Spatial Omics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Spatial Omics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Spatial Omics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Spatial Omics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Spatial Omics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Spatial Omics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Spatial Omics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Spatial Omics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Spatial Omics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Spatial Omics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Spatial Omics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Spatial Omics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Spatial Omics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Spatial Omics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Spatial Omics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Spatial Omics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Spatial Omics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Spatial Omics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Spatial Omics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Spatial Omics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Spatial Omics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Spatial Omics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Akoya Biosciences
  2. 8.1.1 Akoya Biosciences Company Information
  3. 8.1.2 Akoya Biosciences Business Overview
  4. 8.1.3 Akoya Biosciences Spatial Omics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Akoya Biosciences Spatial Omics Product Portfolio
  6. 8.1.5 Akoya Biosciences Recent Developments
  7. 8.2 Biognosys AG
  8. 8.2.1 Biognosys AG Company Information
  9. 8.2.2 Biognosys AG Business Overview
  10. 8.2.3 Biognosys AG Spatial Omics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biognosys AG Spatial Omics Product Portfolio
  12. 8.2.5 Biognosys AG Recent Developments
  13. 8.3 BioSpyder Technologies
  14. 8.3.1 BioSpyder Technologies Company Information
  15. 8.3.2 BioSpyder Technologies Business Overview
  16. 8.3.3 BioSpyder Technologies Spatial Omics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BioSpyder Technologies Spatial Omics Product Portfolio
  18. 8.3.5 BioSpyder Technologies Recent Developments
  19. 8.4 Bio-Techne
  20. 8.4.1 Bio-Techne Company Information
  21. 8.4.2 Bio-Techne Business Overview
  22. 8.4.3 Bio-Techne Spatial Omics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bio-Techne Spatial Omics Product Portfolio
  24. 8.4.5 Bio-Techne Recent Developments
  25. 8.5 Brooks Automation
  26. 8.5.1 Brooks Automation Company Information
  27. 8.5.2 Brooks Automation Business Overview
  28. 8.5.3 Brooks Automation Spatial Omics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Brooks Automation Spatial Omics Product Portfolio
  30. 8.5.5 Brooks Automation Recent Developments
  31. 8.6 Bruker Corporation
  32. 8.6.1 Bruker Corporation Company Information
  33. 8.6.2 Bruker Corporation Business Overview
  34. 8.6.3 Bruker Corporation Spatial Omics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bruker Corporation Spatial Omics Product Portfolio
  36. 8.6.5 Bruker Corporation Recent Developments
  37. 8.7 Danaher Corporation
  38. 8.7.1 Danaher Corporation Company Information
  39. 8.7.2 Danaher Corporation Business Overview
  40. 8.7.3 Danaher Corporation Spatial Omics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Danaher Corporation Spatial Omics Product Portfolio
  42. 8.7.5 Danaher Corporation Recent Developments
  43. 8.8 Diagenode Diagnostics
  44. 8.8.1 Diagenode Diagnostics Company Information
  45. 8.8.2 Diagenode Diagnostics Business Overview
  46. 8.8.3 Diagenode Diagnostics Spatial Omics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Diagenode Diagnostics Spatial Omics Product Portfolio
  48. 8.8.5 Diagenode Diagnostics Recent Developments
  49. 8.9 Dovetail Genomics
  50. 8.9.1 Dovetail Genomics Company Information
  51. 8.9.2 Dovetail Genomics Business Overview
  52. 8.9.3 Dovetail Genomics Spatial Omics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dovetail Genomics Spatial Omics Product Portfolio
  54. 8.9.5 Dovetail Genomics Recent Developments
  55. 8.10 IonPath
  56. 8.10.1 IonPath Company Information
  57. 8.10.2 IonPath Business Overview
  58. 8.10.3 IonPath Spatial Omics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 IonPath Spatial Omics Product Portfolio
  60. 8.10.5 IonPath Recent Developments
  61. 8.11 Nanostring Technologies
  62. 8.11.1 Nanostring Technologies Company Information
  63. 8.11.2 Nanostring Technologies Business Overview
  64. 8.11.3 Nanostring Technologies Spatial Omics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nanostring Technologies Spatial Omics Product Portfolio
  66. 8.11.5 Nanostring Technologies Recent Developments
  67. 8.12 PerkinElmer
  68. 8.12.1 PerkinElmer Company Information
  69. 8.12.2 PerkinElmer Business Overview
  70. 8.12.3 PerkinElmer Spatial Omics Revenue and Gross Margin (2021-2026)
  71. 8.12.4 PerkinElmer Spatial Omics Product Portfolio
  72. 8.12.5 PerkinElmer Recent Developments
  73. 8.13 Rebus Biosystems
  74. 8.13.1 Rebus Biosystems Company Information
  75. 8.13.2 Rebus Biosystems Business Overview
  76. 8.13.3 Rebus Biosystems Spatial Omics Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Rebus Biosystems Spatial Omics Product Portfolio
  78. 8.13.5 Rebus Biosystems Recent Developments
  79. 8.14 S2 Genomics
  80. 8.14.1 S2 Genomics Company Information
  81. 8.14.2 S2 Genomics Business Overview
  82. 8.14.3 S2 Genomics Spatial Omics Revenue and Gross Margin (2021-2026)
  83. 8.14.4 S2 Genomics Spatial Omics Product Portfolio
  84. 8.14.5 S2 Genomics Recent Developments
  85. 8.15 Seven Bridges Genomics
  86. 8.15.1 Seven Bridges Genomics Company Information
  87. 8.15.2 Seven Bridges Genomics Business Overview
  88. 8.15.3 Seven Bridges Genomics Spatial Omics Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Seven Bridges Genomics Spatial Omics Product Portfolio
  90. 8.15.5 Seven Bridges Genomics Recent Developments
  91. 8.16 Vizgen Corporation
  92. 8.16.1 Vizgen Corporation Company Information
  93. 8.16.2 Vizgen Corporation Business Overview
  94. 8.16.3 Vizgen Corporation Spatial Omics Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Vizgen Corporation Spatial Omics Product Portfolio
  96. 8.16.5 Vizgen Corporation Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst